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Background: We describe a method for subcellular fractionation of mouse skeletal muscle, myoblast and myotubes
to obtain relatively pure fractions of nuclear, cytosolic and mitochondrial compartments. Fractionation allows the
analysis of a protein of interest (or other cellular component) based on its subcellular compartmental distribution
and can also generate molecular information about the state of a cell and/or tissue and how the distribution of a
protein may differ between different cellular compartments, tissues or cell types, in response to treatments or
ageing.
Findings: The described method was specifically developed for skeletal muscle and proliferating/differentiated
muscle cells. The purity of the different fractions, representing the cytoplasmic, mitochondrial and nuclear
subcellular compartments was validated by western blot analysis of “house-keeper” marker proteins specific for
each cellular compartment.
Conclusion: This low cost method allowed the mitochondrial, cytoplasmic and nuclear subcellular compartments
from the same starting muscle samples to be rapidly and simultaneously isolated with good purity and without the
use of an ultracentrifuge. This method permits samples to be frozen at −80°C for future analysis and/or additional
processing at a later date.
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Background
Isolation of nuclear, cytosolic and mitochondrial fractions
of reasonable purity from mammalian tissues and cells has
generated great interest as it has the advantage of allowing
different cellular proteins and organelles to be studied and
characterised. Subcellular fractionation is universally used
for various cell types and tissues for sample preparation
and prior to subsequent ~ omics analysis [1-5]. Generic
fractionation protocols exist that can purify specific sub-
cellular compartments and organelles, but in general they
are not tailored for use with skeletal muscle and may re-
quire large amounts of starting material, time, or special
reagents whilst potentially yielding fewer fractions from
the same starting sample etc. [3,5-9]. The protocol
described has been optimized for use with primary skeletal* Correspondence: mjj@liverpool.ac.uk
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reproduction in any medium, provided the ormuscle tissue (e.g. mouse anterior tibialis (AT) muscle)
and both proliferating and differentiated C2C12 cells to
isolate subcellular fractions of nuclei, cytosol, and mito-
chondria from a single starting sample, thereby reducing
the quantity of starting material, cost and total time
needed for sample preparation.
The protocol works well for skeletal muscle tissue and
cells and could be used as a starting point for the frac-
tionation of other non-muscle samples although changes
to buffer volumes; homogenization duration/intensity
etc. may be required. The purity of the fractions
obtained was assessed by immunoblotting for specific
protein markers: histone H3 (nuclei), glyceraldehyde
3-phosphate dehydrogenase (GAPDH, cytosol), and
cytochrome oxidase IV (CoxIV, mitochondria).
Cell culture and animals
The C2C12 mouse skeletal myoblast cell line was
obtained from the American Type Culture Collection
(CRL-1772). C2C12 myoblasts were maintained in
DMEM (Sigma Aldrich, Poole, UK) supplemented withal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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(Biosera, Sussex, UK) and 1% penicillin and strepto-
mycin (Sigma) under an atmosphere of 5% CO2 in
humidified air at 37°C. To induce myogenic differenti-
ation, the growth medium was changed to differentiation
medium (DMEM supplemented with 2% horse serum
(Sigma) and 1% antibiotics) after myoblasts had reached
 90% confluence in a T75 cm2 flask. Myoblast cells
were either harvested at 90% confluence or allowed to
mature to myotubes for 7 days and then harvested
(see below).
Adult mice (C57BL/6) were euthanized by overdose
with anesthetic (ketamine hydrochloride and medatomi-
dine hydrochloride) administered by intraperitoneal in-
jection. Anterior tibialis (AT) muscles, approximately
50 mg wet weight, were rapidly removed and used fresh
to prepare fractions. Experiments were performed in ac-
cordance with UK Home Office Guidelines under the
UK Animals (Scientific Procedures) Act 1986 and
received ethical approval from the University of Liver-
pool Animal Welfare Committee.
Subcellular fractionation
Fresh AT tissue and scraped cells were washed with cold
PBS, cells were pelleted by centrifugation at 200 g for
7 minutes whereas tissues were placed in a pre-chilled
glass Petri dish and minced on ice using sharp scissors.
All samples were resuspended in 300-500 μl of STM
buffer comprising 250 mM sucrose, 50 mM Tris–HCl
pH 7.4, 5 mM MgCl2, protease and phosphatase inhibi-
tor cocktails (all chemicals were from Sigma-Aldrich,
Poole, UK unless stated otherwise) and homogenized for
1 minute on ice using a tight-fitting Teflon pestle
attached to a Potter S homogeniser (Sartorius Stedium,
Goettingen, Germany) set to 600–1,000 rpm. The hom-
ogenate was then inspected, if intact tissue was still evi-
dent the homogenisation was repeated. The homogenate
was decanted into a centrifuge tube and maintained on
ice for 30 minutes, vortexed at maximum speed for
15 seconds and then centrifuged at 800 g for 15 minutes.
The pellet was labelled as P0 and kept on ice, the super-
natant was labelled as S0 and used for subsequent isola-
tion of mitochondrial and cytosolic (Figure 1) fractions.
The pellet P0 (containing nuclei and debris) was resus-
pended in 300-500 μl STM buffer, vortexed at maximum
speed for 15 seconds and then centrifuged at 500 g for
15 minutes. Following the above step, the nuclear pellet
was labelled as P1 and kept on ice, the supernatant S1
(cell debris) was discarded. The purity of the nuclei
within fraction P1 can be quickly determined by micro-
scopic inspection by diluting an aliquot of the fraction in
a trypan blue solution on a haemocytometer. If the P1
fraction contained excess cell debris the above step was
repeated once.To increase the P1 fraction purity further it was
washed in STM buffer (300-500 μl), vortexed at max-
imum speed for 15 seconds and then centrifuged at
1,000 g for 15 minutes. The washed pellet was labelled as
P5 (S5 was discarded) and resuspended in 200-500 μl
NET buffer (comprising: 20 mM HEPES pH 7.9, 1.5 mM
MgCl2, 0.5 M NaCl, 0.2 mM EDTA, 20% glycerol, 1%
Triton-X-100, protease and phosphatase inhibitors)
using a pipette to triturate until homogeneous. Pellet P5
was vortexed at maximum speed for 15 seconds and
incubated on ice for 30 minutes, this fraction contained
the nuclei. The nuclei were lysed with 10–20 passages
through an 18-gauge needle and/or sonicated (using a
Soniprep 150, MSE, London, UK) at high setting for 10–
15 seconds with 30 second pauses whilst being kept on
ice throughout. The lysate was centrifuged at 9,000 g for
30 minutes (at 4°C), the resultant supernatant (S6) was
the final “nuclear fraction” (Figure 1).
Cytosolic and mitochondrial fractions were extracted
from S0 by centrifugation at 800 g for 10 minutes. The
supernatant S2 was saved and the pellet (P2) was dis-
carded, though to improve the nuclear yield the pellet P2
can be combined with fraction P0 (optional step). S2 was
then centrifuged at 11,000 g for 10 minutes and the
supernatant S3 (containing cytosol and microsomal frac-
tion) was precipitated in cold 100% acetone at −20°C for
at least 1 hour followed by centrifugation at 12,000 g for
5 minutes, the pellet (P7) was then resuspended in 100-
300 μl STM buffer and labelled as “cytosolic fraction”
(Figure 1) that likely included some microsomal content.
The pellet P3 was again resuspend in 100-200 μl STM
buffer and centrifuged at 11,000 g for 10 minutes. Once
centrifuged, supernatant S4 was discarded, the mitochon-
drial pellet (P4) was resuspended in 50-100 μl SOL buffer
(comprising: 50 mM Tris HCl pH 6.8, 1 mM EDTA, 0.5%
Triton-X-100, protease and phosphatase inhibitors) by
sonication on ice at high setting for 5–10 seconds with
30 second pauses and labelled as “mitochondrial frac-
tion”. All buffers and centrifugation steps were modified
from Cox and Emili [9] and Psarra et al. [10].
Additionally, a commercial cell fractionation kit
designed to yield near pure nuclei and cytoplasmic frac-
tions from the same starting sample of cells and soft
tissues was used (Thermo NE-PER nuclear and cytoplas-
mic extraction kit, Pierce-Thermo, Northumberland,
UK, to obtain a mitochondrial fraction required the use
of an additional kit) as directed by the manufacturer.
This enabled a comparison of the efficacy of the com-
mercial kit with the method described here when both
methods were used to fractionate an identical starting
sample (myoblast cells from a T75 cm2 flask, approxi-
mately 2×106 cells).
The protein content of each compartment was deter-
mined using BCA protein assay (Sigma).
Figure 1 Schematic representation of the fractionation protocol. The developed protocol provides three subcellular fractions of cytoplasm,
nuclei and mitochondria from a muscle sample. (− − −) Dotted arrow shows an optional step.
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Validation of the purity of the subcellular fractions
derived from the same starting sample was determined
by examining “house-keeper” (HK) protein markers
by standard SDS-PAGE analysis. Protein samples
(15–20 μg/fraction) were separated by a 12% SDS/
PAGE and transferred onto a nitrocellulose mem-
brane (Sigma) and probed using monoclonal anti-
bodies for Histone H3 (Cell Signalling, Hertfordshire,
UK, 1: 2,000), GAPDH (Abcam, Cambridge, UK, 1:
5,000), and Cox IV (Abcam, Cambridge, UK, 1: 2,000)
for nuclei, cytosolic and mitochondrial HK fractions
respectively. Proteins were then visualized after apply-
ing specific secondary HRP-conjugated antibodies and
exposure to a supersignal west dura substrate (Pierce-
Thermo, Northumberland, UK) by use of a Chemi-
DocTM XRS (Bio-Rad, Hertfordshire, UK) see Figure 2
(representative example of at least three replicates per
sample). Secondary antibody controls were also inves-
tigated and no non-specific binding was apparent (data
not shown). To assess the purity of each fraction,
bands relative to sub-compartment protein marker
were quantified by ImageJ software [11].
Results and discussion
After fractionation and extraction of proteins from the
C2C12 cell cultures and AT muscles using the protocoldescribed in Figure 1, we report the mean fraction yield
values obtained from replicate experiments (n = 5)
(Table 1). Figure 2A-C show the nuclear, cytoplasmic
and mitochondrial fractions obtained from a single start-
ing sample from each of the different tissue/cell types.
The fractions were examined by western blotting ana-
lysis using antibodies directed against specific HK mar-
kers and revealed single dense bands for histone H3 at
approximately 17 kDa in the nuclear fraction, a band
representing GAPDH at approximately 37 kDa in the
cytosolic fraction, and a single band at approximately
17 kDa for CoxIV in the mitochondrial fraction
(Figure 2A-C) in each sample.
These analyses showed little contamination between
compartment fractions indicating that the purities of the
nuclear, cytosolic, and mitochondrial fractions were rela-
tively high (Table 2). The HK band intensity was high ar-
guing that enrichment of proteins was achieved during
processing (Table 1). The nuclear and mitochondrial
fractions showed the highest band density indicating
good yields and the lack of equivalent molecular weight
bands in other fractions argued relatively little cross-talk
and indicated reasonable purity, with the myotubes
being slightly more variable depending on the fraction
(feint additional non-specific bands were evident in the
cytosolic fraction from myotubes). Furthermore, analysis
of the distribution of the sub-compartment fraction
Figure 2 Example western blots from three starting samples. In the top panel; (A) myoblast sample (20 μg protein was added to each lane)
fractionated into nuclei, cytoplasmic and mitochondrial samples. Each fraction was run side-by-side on the same blot and then probed separately
against each of the three primary antibodies, Histone-H3, GAPDH and CoxIV, to validate fraction purity. This was repeated for; (B) myotubes
(20 μg protein per lane) and (C) AT tissue (15 μg protein per lane). In the bottom panel; marker protein fraction expression was measured as OD
per resultant band area and was expressed in arbitrary units. The histogram data are representative of the mean (± SEM) of five separate
experiments.
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centage of purity was 85.6% (Cox IV mitochondrial
marker in myoblasts) and therefore argued less than
15% was from other sources.
Comparison of the method described with a commer-
cially available fractionation kit showed both approaches
generated clean and abundant cytoplasmic fractions
(Figure 3A), although the yield using the kit was
smaller. The nuclear fraction generated by the kit
showed both reduced yield and compromised purity
(Figure 3B). The kit was not designed to generate aTable 1 Fraction yields for myoblast, myotube and AT tissue
Sample Mean protein yield (μg)
Nuclei Cyto
Myoblast 1179± 100 (150μL) 496± 25 (100μL)
Myotube 1624± 107 (150μL) 547± 4 (100μL)
AT tissue 3294± 254 (300μL) 1486 ± 225(300μL)
Typical protein yield (μg) obtained after sample fractionation using the indicated vo
2×106 cells) and AT muscle (all n = 5, mean ± SEM). The protein yields (determined
fraction) are representative and dependent upon the volume of buffer utilized to remitochondrial fraction and so no equivalent compari-
son was undertaken.
Conclusion
In comparison with the described protocol, the yield
obtained with the commercial kit as indicated by band
density, was poor and only the cytoplasmic fraction
appeared relatively pure. The kit is designed for more
generic use with multiple cells and soft tissues and may
explain the inability to generate a pure and abundant




97 ± 13 (50μL) 1.8 ± 0.1 5
197± 15 (50μL) 2.4 ± 0.2 5
444± 60 (100μL) 5.2 ± 0.5 5
lume of lysis buffer for myoblasts, myotubes (both cultured in 75 cm2 flask,
by BCA assay as total volume of a fraction × protein concentration in the
suspend each fraction.
Table 2 Purity analysis of the yield of sub-compartmental
marker proteins
Fraction/Marker Myoblasts Myotubes AT Tissue
Nuclei/Histone H3 (%) 92.7 ± 1.3 86.4 ± 1.4 88.0 ± 0.9
Cyto/GAPDH (%) 92.4 ± 0.5 93.9 ± 1.4 87.8 ± 0.3
Mito/CoxIV (%) 85.6 ± 0.9 92.1 ± 0.5 91.2 ± 0.1
The percentage shown in the table is obtained by the ratio between OD
values of Histone H3, GAPDH and CoxIV (all n = 5, mean ± SEM) in an individual
target compartment divided by the sum of the OD values present in all
compartments in each sample.
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an additional kit to purify a mitochondrial (and cytoplas-
mic) fraction would be required and this would increase
the cost and time requirement.
In conclusion the method for subcellular fractionation
described here is inexpensive, does not require an ultra-
centrifuge and was found to generate three relatively
abundant subcellular fractions of reasonable purity. This
method of subcellular fractionation could be combined
with proteomics research wherein protein patterns of
subcellular fractions could be mapped and characterized
by 2D gel analysis and mass spectrometry.Figure 3 Comparison of fractions generated from a muscle
source by a kit versus the described method. Example western
blot to compare sample purity generated after using a commercial
cell fractionation kit (K = kit) versus the method reported here
(NK= not kit). The kit was used to generate nuclear and cytoplasmic
fractions only, these were compared for purity and yield against the
method described by probing both fractions for (A) GAPDH and
(B) Histone-H3. The C2C12 myotube fractions obtained from both
methods were analysed on the same western blot (20 μg protein
was loaded from each fraction).Competing interests
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